Siliconomas

Dornelas, Marilho Tadeu; Corrêa, Marília de Pádua Dornelas; Barra, Felipe Marcellos Lemos; Sá, Carlos Alberto Correa de; Dornelas, Marcília de Cássia; Sant'Anna, Ludmila Leite; Netto, Gabriel de Mendonça; Arruda, Fabrizio Romagnoli de

doi:10.1590/s1983-51752011000100005

Cited by 6 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Often, unless a surgical indication is clear, suppressive therapy is tried either with long-term antibiotics or with corticosteroids. 8,34…”

Section: Discussionmentioning

confidence: 99%

“…Often, unless a surgical indication is clear, suppressive therapy is tried either with long-term antibiotics or with corticosteroids. 8,34 If they are not symptomatic or do not interfere with the diagnosis of tumor recurrence, they do not require resection and may be only observed. Although the optimal treatment for the management of these granulomatous lesions is surgical excision, this can lead to debilitating surgeries due to multistage silicone infiltration, often requiring reconstruction with autologous flaps.…”

Section: Management and Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Management of Contralateral Breast and Axillary Nodes Silicone Migration after Implant Rupture

Elahi

Meuwly

Meuwly³

et al. 2022

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

Background: Silicone implants were developed in 1962 for breast augmentation and became essential in reconstruction after mastectomy. Silicone “bleeding” has been described from both ruptured and intact implants and can induce disseminated granulomatosis due to the component's high fat solubility. If not adequately treated, they can lead to disastrous cosmetic and functional consequences. Because they may mimic malignancy, prompt and reliable diagnosis should be made as early as possible. Methods: We present a clinical case description of multiple intraparenchymal and ipsi/contralateral intraganglionic siliconomas in a woman who had undergone breast reconstruction, and a literature review of the pathophysiology of siliconomas and their diagnosis and management. Results: Silicone migration to the contralateral breast and lymph node is rare and has seldom been described. The mechanism is still debated. Excluding malignancy is a priority, and systematic management must be respected to avoid misdiagnosis or unnecessary investigations. Conclusions: A multidisciplinary approach is essential for siliconoma management. Silicone-related lymphadenopathies do not require follow-up or special treatment unless they interfere with the diagnosis of tumor recurrence. Careful observation is sufficient for asymptomatic siliconomas; however, symptomatic ones should be treated depending on skin involvement and the patient's eligibility for intervention.

show abstract

“…Often, unless a surgical indication is clear, suppressive therapy is tried either with long-term antibiotics or with corticosteroids. 8,34…”

Section: Discussionmentioning

confidence: 99%

Section: Management and Treatmentmentioning

confidence: 99%

Management of Contralateral Breast and Axillary Nodes Silicone Migration after Implant Rupture

Elahi

Meuwly

Meuwly³

et al. 2022

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

show abstract

“…The term, siliconoma, was popularized in 1965 to characterize the foreign body reaction similar to that described in the case of other liquids such as paraffin [2][3][4]. Adverse effects and complications of injectable liquid silicone used as a filler can be acute, such as edema, ecchymosis, erythema, and dyschromia [2], or late, as granulomatous reactions, idiosyncratic reactions, migration, connective tissue disease, silicone embolization syndrome [5], and even death. Diagnosis can be difficult when the previous history of the injections of the substance is not known; the adverse effects can occur 20 to 30 years after the procedure [2,-4, 6].…”

Section: Discussionmentioning

confidence: 99%